Shedding Light on Immunotherapy for Cancer
- 1 April 2004
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 350 (14), 1461-1463
- https://doi.org/10.1056/nejmcibr045001
Abstract
There are two experimental approaches to treat cancer through tweaking the immune system; both depend on T lymphocytes' having access to tumor. A recent study involving a mouse model demonstrates the importance of accessibility and is thus relevant to both approaches.Keywords
This publication has 5 references indexed in Scilit:
- Priming of naive T cells inside tumors leads to eradication of established tumorsNature Immunology, 2004
- Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T CellsThe Journal of Experimental Medicine, 2003
- Natural selection of tumor variants in the generation of “tumor escape” phenotypesNature Immunology, 2002
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanomaNature Medicine, 1998